guidelines:
  1: ORBIT_bleeding_risk_score.v1
test_cases:
- id: M, age 74, Hb 13 g/dL, Ht 40, GFR 60, ORBIT score 0
  input:
    1:
      gt0003|Gender: local::at0005|Male|
      gt0004|Age: 74,a
      gt0006|Haemoglobin: 13,gm/dl
      gt0007|Hematocrit: 40,%
      gt0009|GFR: 60,ml/min
      gt0011|Bleeding history: 0|local::at0011|No|
      gt0012|Treatment with antiplatelet agents: 0|local::at0017|No|
  expected_output:
    1:
      gt0015|Age: 0|local::at0008|<= 74 years|
      gt0014|Reduced Hemoglobin or Hematocrit: 0|local::at0005|No|
      gt0016|GFR: 0|local::at0014|>= 60 mL/min/1.73 m2|
      gt0017|ORBIT Score: 0
      gt0020|Bleeds per 100 patient-years: 0|local::at0007|2.4|
      gt0019|Risk group: 0|local::at0003|Low|

- id: M, age 74, Hb 130 g/L, Ht 40, GFR 59, ORBIT score 2
  input:
    1:
      gt0003|Gender: local::at0005|Male|
      gt0004|Age: 74,a
      gt0006|Haemoglobin: 130,gm/l
      gt0007|Hematocrit: 40,%
      gt0009|GFR: 59,ml/min
      gt0011|Bleeding history: 0|local::at0011|No|
      gt0012|Treatment with antiplatelet agents: 1|local::at0018|Yes|
  expected_output:
    1:
      gt0015|Age: 0|local::at0008|<= 74 years|
      gt0014|Reduced Hemoglobin or Hematocrit: 0|local::at0005|No|
      gt0016|GFR: 1|local::at0015|< 60 mL/min/1.73 m2|
      gt0017|ORBIT Score: 2
      gt0020|Bleeds per 100 patient-years: 0|local::at0007|2.4|
      gt0019|Risk group: 0|local::at0003|Low|

- id: F, age 75, Hb 12 g/dL, Ht 37, GFR 59, ORBIT score 3
  input:
    1:
      gt0003|Gender: local::at0006|Female|
      gt0004|Age: 75,a
      gt0006|Haemoglobin: 12,gm/dl
      gt0007|Hematocrit: 37,%
      gt0009|GFR: 59,ml/min
      gt0011|Bleeding history: 0|local::at0011|No|
      gt0012|Treatment with antiplatelet agents: 1|local::at0018|Yes|
  expected_output:
    1:
      gt0015|Age: 1|local::at0009|> 74 years|
      gt0014|Reduced Hemoglobin or Hematocrit: 0|local::at0005|No|
      gt0016|GFR: 1|local::at0015|< 60 mL/min/1.73 m2|
      gt0017|ORBIT Score: 3
      gt0020|Bleeds per 100 patient-years: 1|local::at0008|4.7|
      gt0019|Risk group: 1|local::at0004|Medium|

- id: F, age 75, Hb 120 g/L, Ht 37, GFR 59, ORBIT score 4
  input:
  input:
    1:
      gt0003|Gender: local::at0006|Female|
      gt0004|Age: 75,a
      gt0006|Haemoglobin: 120,gm/l
      gt0007|Hematocrit: 37,%
      gt0009|GFR: 59,ml/min
      gt0011|Bleeding history: 2|local::at0012|Yes|
      gt0012|Treatment with antiplatelet agents: 0|local::at0017|No|
  expected_output:
    1:
      gt0015|Age: 1|local::at0009|> 74 years|
      gt0014|Reduced Hemoglobin or Hematocrit: 0|local::at0005|No|
      gt0016|GFR: 1|local::at0015|< 60 mL/min/1.73 m2|
      gt0017|ORBIT Score: 4
      gt0020|Bleeds per 100 patient-years: 2|local::at0009|8.1|
      gt0019|Risk group: 2|local::at0005|High|

- id: F, age 75, Hb 11 g/dL, Ht 36, GFR 59, ORBIT score 5
  input:
    1:
      gt0003|Gender: local::at0006|Female|
      gt0004|Age: 75,a
      gt0006|Haemoglobin: 11,gm/dl
      gt0007|Hematocrit: 36,%
      gt0009|GFR: 59,ml/min
      gt0011|Bleeding history: 0|local::at0011|No|
      gt0012|Treatment with antiplatelet agents: 1|local::at0018|Yes|
  expected_output:
    1:
      gt0015|Age: 1|local::at0009|> 74 years|
      gt0014|Reduced Hemoglobin or Hematocrit: 2|local::at0006|Yes|
      gt0016|GFR: 1|local::at0015|< 60 mL/min/1.73 m2|
      gt0017|ORBIT Score: 5
      gt0020|Bleeds per 100 patient-years: 2|local::at0009|8.1|

- id: M, age 75, Hb 12 g/dL, Ht 39, GFR 59, ORBIT score 6
  input:
    1:
      gt0003|Gender: local::at0005|Male|
      gt0004|Age: 75,a
      gt0006|Haemoglobin: 12,gm/dl
      gt0007|Hematocrit: 39,%
      gt0009|GFR: 59,ml/min
      gt0011|Bleeding history: 2|local::at0012|Yes|
      gt0012|Treatment with antiplatelet agents: 0|local::at0017|No|
  expected_output:
    1:
      gt0015|Age: 1|local::at0009|> 74 years|
      gt0014|Reduced Hemoglobin or Hematocrit: 2|local::at0006|Yes|
      gt0016|GFR: 1|local::at0015|< 60 mL/min/1.73 m2|
      gt0017|ORBIT Score: 6
      gt0020|Bleeds per 100 patient-years: 2|local::at0009|8.1|
      gt0019|Risk group: 2|local::at0005|High|
      gt0019|Risk group: 2|local::at0005|High|

- id: ORBIT score 7 (max)
  input:
    1:
      gt0003|Gender: local::at0005|Male|
      gt0004|Age: 75,a
      gt0006|Haemoglobin: 12,gm/dl
      gt0007|Hematocrit: 39,%
      gt0009|GFR: 59,ml/min
      gt0011|Bleeding history: 2|local::at0012|Yes|
      gt0012|Treatment with antiplatelet agents: 1|local::at0018|Yes|
  expected_output:
    1:
      gt0015|Age: 1|local::at0009|> 74 years|
      gt0014|Reduced Hemoglobin or Hematocrit: 2|local::at0006|Yes|
      gt0016|GFR: 1|local::at0015|< 60 mL/min/1.73 m2|
      gt0017|ORBIT Score: 7
      gt0020|Bleeds per 100 patient-years: 2|local::at0009|8.1|
      gt0019|Risk group: 2|local::at0005|High|